Life Biosciences
Providing comprehensive animal behavior analysis and a full suite of advanced scientific services for cutting-edge research and diagnostics.
Providing comprehensive animal behavior analysis and a full suite of advanced scientific services for cutting-edge research and diagnostics.
Life Biosciences, founded in 2021, is a biotechnology and healthcare startup that specializes in providing comprehensive animal behavior analysis and a full suite of advanced scientific services for cutting-edge research and diagnostics. The company's expertise encompasses a wide range of services including blood biochemistry, routine blood testing, pathological staining, immunohistochemistry, and molecular experiments, among others. In their last funding round, Life Biosciences secured a substantial CNY90.00M Series A investment on 10 April 2023, with participation from SDIC Ventures and Haina Rongzhi Venture Capital. This investment is indicative of the confidence these prominent investors have in the potential of Life Biosciences and its innovative approach in the biotechnology and healthcare sectors. With its strategic focus on revolutionizing animal behavior analysis and advanced scientific services, Life Biosciences is well-positioned to make significant contributions to the pharmaceutical industry. The company’s commitment to leveraging cutting-edge technology for research and diagnostics underscores its potential to drive impactful innovation in the healthcare and biotechnology domains.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY90.00M | 2 |
|
10 Apr 2023 |
| Series A | CNY170.00M | 4 |
|
29 Dec 2022 |
No recent news or press coverage available for Life Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
